OCT 13, 2019 8:43 AM PDT

New diagnostic tool for thyroid cancer

Thyroid cancer diagnoses have risen in the last thirty years from 6 per 100,000 to more than 14 per 100,000. That’s according to the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI), which also reports that in 2016, 822,242 people in the US had thyroid cancer. However, new research published in PNAS provides hope in light of these grim numbers.

The diagnostic process for thyroid cancer involves taking a biopsy using a fine needle aspiration (FNA); however, because FNA biopsies are inconclusive 1 out of 5 times at identifying cancer, doctors may often recommend surgery to remove part or all of the thyroid to play it safe. The problem with this is that those patients who receive surgery on their thyroids are required to take hormone replacement therapy for the entirety of their lives to be able to regulate metabolism, heart rate, body temperature, and blood pressure.

"If we could prevent people from having surgery they don't need and enable them to have a more precise diagnosis," says co-senior author of the study Livia S. Eberlin, Ph.D., assistant professor of chemistry and diagnostic medicine at The University of Texas at Austin, "we can improve treatment for patients and lower costs for the healthcare system."

The study details how the Eberlin and fellow researchers used mass spectrometry imaging to develop a molecular fingerprint for thyroid cancer based on the molecular profiles from tissues of 178 people with or without thyroid cancer.

Using this new molecular fingerprint proved to be successful in cutting the number of false-positive results from FNA procedures. As compared to the current FNA procedure, the new fingerprint test produced false-positive results in only 1 in 10 cases approximately. To put that into clearer human numbers, this could keep 17 people from undergoing unnecessary surgery.

With this new FNA development, patients would receive fewer unnecessary surgeries. Photo: Pixabay

"With this next-generation test," says co-senior study author Dr. James W. Suliburk, "we can provide thyroid cancer diagnoses faster and with more precision than current techniques — this will be the new state-of-the-art. We are able to do this analysis directly on the FNA sample and much more rapidly than the current process, which could take between 3 and 30 days." The researchers plan to continue their work with a 2-year trial to validate the FNA findings of roughly 1,000 people in the US, Brazil, and Australia.

Sources: PNAS, Medical News Today

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 18, 2021
Cancer
Cancer cell lines are too dissimilar from human cancer cells
JUN 18, 2021
Cancer cell lines are too dissimilar from human cancer cells
A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
AUG 12, 2021
Clinical & Molecular DX
Computers Pick Up the 'Sound' of Thyroid Cancer
AUG 12, 2021
Computers Pick Up the 'Sound' of Thyroid Cancer
Researchers have developed a new technology for the non-invasive diagnosis of thyroid cancer that combines photoacoustic ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
OCT 21, 2021
Cancer
Exercise: A Secret Weapon to Combat Prostate Cancer?
OCT 21, 2021
Exercise: A Secret Weapon to Combat Prostate Cancer?
Exercise oncology is an evolving science that considers the addition of physical activity regimens to the treatment ...
Loading Comments...